CardiacSense is an innovative startup specializing in wearable medical technology, specifically designed to monitor heart health. The company's flagship product is a medical-grade watch that continuously tracks heart rate and detects arrhythmias, such as atrial fibrillation (AF). This watch has demonstrated high accuracy, with clinical studies showing 99% sensitivity and 99% specificity in distinguishing AF from normal heart rhythms.

CardiacSense primarily serves healthcare professionals, patients, and telemedicine providers. The company operates in the global healthcare market, with regulatory approvals in regions like Israel and the European Union, and significant contracts in countries such as India.

The business model of CardiacSense revolves around the sale of its medical watches to healthcare providers and institutions. These entities then use the watches for remote patient monitoring and telemedicine services. By providing continuous and accurate heart monitoring, CardiacSense helps healthcare providers offer better care to patients, especially those with chronic heart conditions.

CardiacSense generates revenue through direct sales of its medical watches and potentially through partnerships with healthcare organizations and telemedicine companies. The company has secured substantial contracts, such as a $32.4 million deal in India, which underscores its growing market presence and the demand for its technology.

In summary, CardiacSense is a key player in the wearable medical technology market, offering advanced heart monitoring solutions that cater to healthcare providers and patients worldwide. Its business model focuses on sales and partnerships, ensuring a steady revenue stream as it expands its market reach.

Keywords: Wearable Technology, Heart Monitoring, Atrial Fibrillation, Medical Watch, Telemedicine, Remote Patient Monitoring, Healthcare, Clinical Accuracy, Global Market, Revenue Growth.